Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction

Cardiovascular Research

Volumn 59, Issue 4, 2003, Pages 997-1005

  Hershey, James C ^a   Corcoran, Halea A ^a   Baskin, Elizabeth P ^a   Gilberto, David B ^a   Mao, Xianzhi ^a   Thomas, Kenneth A ^a   Cook, Jacquelynn J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Angiogenesis; Arteries; Blood flow; Collateral circulation; Growth factors

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; COLLATERAL CIRCULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EXTRACTION; FEMORAL ARTERY; GASTROCNEMIUS MUSCLE; HEMODYNAMICS; HINDLIMB; MALE; NONHUMAN; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; RABBIT; THIGH;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERIES; CAPILLARIES; COLLATERAL CIRCULATION; FEMORAL ARTERY; FIBROBLAST GROWTH FACTOR 1; HINDLIMB; ISCHEMIA; MALE; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; REGIONAL BLOOD FLOW; STIMULATION, CHEMICAL;

EID: 1642347921     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00522-4     Document Type: Article

References (33)

1. Criqui M.H., Fronek A., Barrett-Connor E., et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 71:1985;510-515.
2. Baumgartner I., Rauh G., Pieczek A., et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med. 6:2000;880-884.
3. Hershey JC, Baskin EP, Corcoran HA, et al. VEGF stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart and Vessels (in press).
4. Lee R.J., Springer M.L., Blanco-Bose W.E., et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation. 102:2000;898-901.
5. Lazarous D.F., Shou M., Scheinowitz M., et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 94:1996;1074-1082.
6. Masaki I., Yonemitsu Y., Yamashita A., et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res. 90:2002;966-973.
7. Deindl E., Buschmann I., Hoefer I.E., et al. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res. 89:2001;779-786.
8. Helisch A., Schaper W. Angiogenesis and arteriogenesis - not yet for prescription. Z Kardiol. 89:2000;239-244.
9. Epstein S.E., Kornowski R., Fuchs S., Dvork H.F. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation. 104:2001;115-119.
10. Mellin T.N., Mennie R.J., Cashen D.E., et al. Acidic fibroblast growth factor accelerates dermal wound healing. Growth Factors. 7:1992;1-14.
11. Bjornsson T.D., Dryjski M., Tluczek J., et al. Acidic fibroblast growth factor promotes vascular repair. Proc. Natl. Acad. Sci. USA. 88:1991;8651-8655.
12. Lopez J.J., Edelman E.R., Stamler A., et al. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am J Physiol. 274:1998;H930-H936.
13. Sellke F.W., Li J., Stamler A., et al. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery. 120:1996;182-188.
14. Linemeyer D.L., Menke J.G., Kelly L.J., et al. Disulfide bonds are neither required, present, nor compatible with full activity of human recombinant acidic fibroblast growth factor. Growth Factors. 3:1990;287-298.
15. Ortega S., Schaeffer M.T., Soderman D., et al. Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. J. Biol. Chem. 266:1991;5842-5846.
16. Hershey J.C., Baskin E.P., Glass J.D., et al. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res. 49:2001;618-625.
17. Takeshita S., Rossow S.T., Kearney M., et al. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in the rabbit model of lower limb insufficiency. Am J Pathol. 147:1995;1649-1660.
18. Zaida A.M., Hudlicka O., Tyler K.R., Wright A.J. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res. 18:1984;724-732.
19. Baffour R.J., Berman J., Garb J.L., et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia. J Vasc Surg. 16:1992;181-191.
20. Hendricks D.L., Pevec W.C., Shestak K.C., et al. A model of persistent partial hindlimb ischemia in the rabbit. J Surg. Res. 49:1990;453-457.
21. Mackie B.G., Terjung R.L. Blood flow to different skeletal muscle fiber types during contraction. Am J Physiol Heart Circ Physiol. 245:1983;H265-H275.
22. Yang H.T., Feng Y., Allen L.A., Protter A., Terjung R.L. Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency. Am J Physiol Heart Circ Physiol. 278:2000;H1966-H1973.
23. Tabata H., Silver M., Isner J.M. Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. Cardiovasc Res. 35:1997;470-479.
24. Lederman R.J., Mendelsohn F.O., Anderson R.D., et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet. 359:2002;2053-2058.
25. Yang H.T., Deschenes M.R., Ogilvie R.W., Terjung R.L. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 76:1996;62-69.
26. Ito W.D., Arras M., Scholz D., et al. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol. 42:1997;H1255-H1265.
27. Deindl E., Hoefer I.E., Fernandez B., et al. Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogenesis. Circ Res. 92:2003;561-568.
28. van Royen N., Piek J.J., Buschmann I., et al. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 49:2001;543-553.
29. Arras M., Ito W.D., Sholz D., et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101:1998;40-50.
30. Battler A.M., Scheinowitz A., Bor D., et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J. Am. Coll. Cardiol. 22:1993;2001-2006.
31. Lindner V., Lappi D.A., Baird A., Majack R.A., Reidy M.A. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 68:1991;106-113.
32. Yang H.T., Ogilvie R.W., Terjung R.L. Heparin increases exercise-induced collateral blood flow in rats with femoral artery ligation. Circ Res. 76:1995;448-456.
33. Yang H.T., Ogilvie R.W., Terjung R.L. Exercise training enhances basic fibroblast growth factor-induced collateral blood flow. Am J Physiol Heart Circ Physiol. 274:1998;H2053-H2061.